Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 02, 2023 10:14 ET | Source: Pharma Equity Group A/S

Forløb af ekstraordinær generalforsamling i Pharma Equity Group A/S

2. november 2023 Meddelelse nr. 43 Forløb af ekstraordinær generalforsamling i Pharma Equity Group A/S Pharma Equity Group A/S afholdte i dag ekstraordinær generalforsamling, hvor...
November 02, 2023 10:14 ET | Source: Pharma Equity Group A/S

Resolutions of the Extraordinary General Meeting of Pharma Equity Group A/S

2 November 2023 Announcement no. 43 Resolutions of the Extraordinary General Meeting of Pharma Equity Group A/S Pharma Equity Group A/S today held its Extraordinary General Meeting with...
October 31, 2023 08:18 ET | Source: Pharma Equity Group A/S

Pharma Equity Group’s datterselskab (Reponex Pharmaceuticals A/S) modtager EPO meddelelse om udstedelse af patenter på behandling med datterselskabets sårhelende lægemiddelkombination samt behandling mod Colorektal Cancer.

31. oktober 2023 Selskabsmeddelelse nr. 42 Pharma Equity Group’s datterselskab (Reponex Pharmaceuticals A/S) modtager European Patent Office (EPO) meddelelse om udstedelse af patent på behandling...
October 31, 2023 08:18 ET | Source: Pharma Equity Group A/S

Pharma Equity Group's subsidiary (Reponex Pharmaceuticals A/S) receives a notification from the EPO regarding the “Intention to Grant” for patents of the subsidiary's wound-healing drug combination and the treatment of colorectal cancer.

October 31, 2023 Company Announcement No. 42 Pharma Equity Group's subsidiary (Reponex Pharmaceuticals A/S) receives a notification from the European Patent Office (EPO) regarding the...
October 31, 2023 06:57 ET | Source: Pharma Equity Group A/S

Pharma Equity Group’s datterselskab (Reponex Pharmaceuticals A/S) har modtaget meddelelse om godkendelse af patent på behandling med datterselskabets sårhelende lægemiddelkombination.

31. oktober 2023 Selskabsmeddelelse nr. 41 Pharma Equity Group’s datterselskab (Reponex Pharmaceuticals A/S) har modtaget meddelelse om godkendelse af patent på behandling med datterselskabets...
October 31, 2023 06:57 ET | Source: Pharma Equity Group A/S

Pharma Equity Group’s subsidiary company (Reponex Pharmaceuticals A/S) have received grant of US Patent for a method of treatment on its topical wound-healing composition.

31 October 2023 Announcement no. 41 Pharma Equity Group’s subsidiary company (Reponex Pharmaceuticals A/S) have received grant of US Patent for a method of treatment on its topical wound-healing...
October 11, 2023 06:27 ET | Source: Pharma Equity Group A/S

Indkaldelse til ekstraordinær generalforsamling i Pharma Equity Group A/S

11. oktober 2023 Meddelelse nr. 40 Indkaldelse til ekstraordinær generalforsamling i Pharma Equity Group A/S ("Selskabet") 2. november 2023 kl. 15:00 (dansk tid) hos Wihlborgs kantinerSlotsmarken...
October 11, 2023 06:27 ET | Source: Pharma Equity Group A/S

Notice convening the extraordinary general meeting of Pharma Equity Group A/S

11 October 2023 Announcement no. 40 Notice convening the extraordinary general meeting of Pharma Equity Group A/S (the "Company") November 2, 2023, at 3 PM CET at Wihlborg's CanteensSlotsmarken...
September 25, 2023 14:49 ET | Source: Pharma Equity Group A/S

Status for Selskabets tilgodehavende fra Portinho S.A.

25. september 2023 Meddelelse nr. 39 Status for Selskabets tilgodehavende fra Portinho S.A. I det konsoliderede regnskab (med datterselskabet Reponex Pharmaceuticals A/S) pr. 30. juni 2023 har...
September 25, 2023 14:49 ET | Source: Pharma Equity Group A/S

Status of the Company's receivables from Portinho S.A.

25. September 2023 Announcement no. 39 Status of the Company's receivables from Portinho S.A. In the consolidated financial statement (with the subsidiary Reponex Pharmaceuticals A/S) as of 30...